B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site

Hyalex Orthopaedics, a privately-held medical device company developing transformational cartilage biomimetic products, today announced the appointment of Carl Vause as its new chief executive officer and president.

FDA Authorization of STERIS Mask Decontamination System a “Game Changer for Our Heroes on the Front Lines”

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today released the following statement from President and CEO Scott Whitaker on STERIS’s Emergency Use Authorization (EUA) from FDA for certain V-PRO® Low Temperature Sterilization Systems to allow health care providers to decontaminate N95…

Privacy Policy

By visiting the AdvaMed Website, you accept and consent to the practices described in the Privacy Policy. 

Terms of Use

By using this website you agree that you understand, accept and agree to these Terms of Use. 

AdvaMed Re-Launches Web-Based Platform to Assist Government with Potential Supply Shortfalls

AdvaMed unveiled a newly repurposed platform to help device manufacturers locate and partner with thousands of component part manufacturers and sellers, should they need them during the COVID pandemic.

AdvaMed Expands VentConnect Platform to Advance Production of COVID MedTech

WASHINGTON, D.C. – To ensure production of vital medical devices and diagnostic tests during this critical time and to help prevent future supply chain issues, the Advanced Medical Technology Association (AdvaMed) announced that…

AdvaMed Applauds President’s Focus on Testing, Vaccination

AdvaMed, the world’s leading trade association for medical technology companies—which includes the diagnostics companies that make Covid-19 tests—released the following statement from president and CEO Scott Whitaker:

AdvaMed Announces VentConnect Online Platform to Scale the Production and Distribution of Ventilators

WASHINGTON, D.C. – As part of the medical technology industry’s multi-front battle to combat the coronavirus (COVID-19) pandemic, today the Advanced Medical Technology Association (AdvaMed) announced the launch of a new…

14th Annual FDA/AdvaMed Medical Device Statistical Issues Conference

This annual conference brings together leading authorities from FDA, industry and academia to address the latest statistical trends and issues facing medtech organizations.

AdvaMed’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 Million

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…